• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BolA 家族成员在卵巢癌中的表达谱及预后价值。

Expression profiles and prognostic values of BolA family members in ovarian cancer.

机构信息

Department of Nursing, Shengjing Hospital of China Medical University, No.36 Sanhao Street, Shenyang, Liaoning, 110004, People's Republic of China.

出版信息

J Ovarian Res. 2021 Jun 2;14(1):75. doi: 10.1186/s13048-021-00821-0.

DOI:10.1186/s13048-021-00821-0
PMID:34078439
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8170995/
Abstract

BACKGROUND

The BOLA gene family, comprising three members, is mainly involved in regulating intracellular iron homeostasis. Emerging evidence suggests that BolA family member 2 plays a vital role in tumorigenesis and hepatic cellular carcinoma progression. However, there was less known about its role in ovarian cancer.

METHODS

In the present study, we investigated the expression profiles, prognostic roles, and genetic alterations of three BolA family members in patients with ovarian cancer through several public databases, containing Oncomine and Gene Expression Profiling Interactive Analysis, Human Protein Atlas, Kaplan-Meier plotter and cBioPortal. Then, we constructed the protein-protein interaction networks of BOLA proteins and their interactors by using the String database and Cytoscape software. In addition, we performed the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment by the Annotation, Visualization, and Integrated Discovery database. Finally, we explored the mechanisms underlying BolA family members' involvement in OC by using gene set enrichment analysis.

RESULTS

The mRNA and protein expression levels of BOLA2 and BOLA3 were heavily higher in ovarian cancer tissues than in normal ovarian tissues. Dysregulated mRNA expressions of three BolA family members were significantly associated with prognosis in overall or subgroup analysis. Moreover, genetic alterations also occurred in three BolA family members in ovarian cancer. GO analysis indicated that BolA family members might regulate the function of metal ion binding and protein disulfide oxidoreductase activity. Gene set enrichment analysis indicated that BolA family members were mainly associated with oxidative phosphorylation, proteasome, protein export, and glutathione metabolism in ovarian cancer.

CONCLUSION

In brief, our finding may contribute to increasing currently limited prognostic biomarkers and treatment options for ovarian cancer.

摘要

背景

BOLA 基因家族由三个成员组成,主要参与调节细胞内铁稳态。新出现的证据表明,BolA 家族成员 2 在肿瘤发生和肝细胞癌进展中起着至关重要的作用。然而,关于其在卵巢癌中的作用知之甚少。

方法

在本研究中,我们通过 Oncomine 和基因表达谱交互式分析、人类蛋白质图谱、Kaplan-Meier plotter 和 cBioPortal 等多个公共数据库,研究了三个 BolA 家族成员在卵巢癌患者中的表达谱、预后作用和遗传改变。然后,我们使用 String 数据库和 Cytoscape 软件构建了 BOLA 蛋白及其相互作用蛋白的蛋白质-蛋白质相互作用网络。此外,我们通过 Annotation、Visualization、and Integrated Discovery 数据库进行了基因本体论 (GO) 和京都基因与基因组百科全书 (KEGG) 通路富集分析。最后,我们通过基因集富集分析探讨了 BolA 家族成员参与 OC 的机制。

结果

BOLA2 和 BOLA3 的 mRNA 和蛋白表达水平在卵巢癌组织中明显高于正常卵巢组织。三个 BolA 家族成员的失调 mRNA 表达与总分析或亚组分析中的预后显著相关。此外,三个 BolA 家族成员在卵巢癌中也发生了遗传改变。GO 分析表明,BolA 家族成员可能调节金属离子结合和蛋白质二硫键氧化还原酶活性的功能。基因集富集分析表明,BolA 家族成员在卵巢癌中主要与氧化磷酸化、蛋白酶体、蛋白质输出和谷胱甘肽代谢有关。

结论

总之,我们的发现可能有助于增加目前有限的卵巢癌预后生物标志物和治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ea/8170995/1a72b2006b03/13048_2021_821_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ea/8170995/ea81ee78d381/13048_2021_821_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ea/8170995/15e8831c0076/13048_2021_821_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ea/8170995/102be2110d2a/13048_2021_821_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ea/8170995/ae8f48a35b30/13048_2021_821_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ea/8170995/395fca2aa2e8/13048_2021_821_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ea/8170995/54f971c50d88/13048_2021_821_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ea/8170995/1a72b2006b03/13048_2021_821_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ea/8170995/ea81ee78d381/13048_2021_821_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ea/8170995/15e8831c0076/13048_2021_821_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ea/8170995/102be2110d2a/13048_2021_821_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ea/8170995/ae8f48a35b30/13048_2021_821_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ea/8170995/395fca2aa2e8/13048_2021_821_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ea/8170995/54f971c50d88/13048_2021_821_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a6ea/8170995/1a72b2006b03/13048_2021_821_Fig7_HTML.jpg

相似文献

1
Expression profiles and prognostic values of BolA family members in ovarian cancer.BolA 家族成员在卵巢癌中的表达谱及预后价值。
J Ovarian Res. 2021 Jun 2;14(1):75. doi: 10.1186/s13048-021-00821-0.
2
Comprehensive Analysis of Expression and Prognostic Value of Sirtuins in Ovarian Cancer.卵巢癌中沉默调节蛋白的表达及预后价值的综合分析
Front Genet. 2019 Sep 13;10:879. doi: 10.3389/fgene.2019.00879. eCollection 2019.
3
Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis.miR-182 在卵巢癌中的预后价值及潜在通路信号分析:基于基因表达综合数据库(GEO)和生物信息学分析的研究。
J Ovarian Res. 2019 Nov 8;12(1):106. doi: 10.1186/s13048-019-0580-7.
4
Prognostic Values of BolA Family Member Expression in Hepatocellular Carcinoma.BolA 家族成员表达在肝细胞癌中的预后价值。
Biomed Res Int. 2022 Aug 16;2022:8360481. doi: 10.1155/2022/8360481. eCollection 2022.
5
Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis.生物信息学分析鉴定卵巢癌的潜在治疗靶点和预后标志物。
Biomed Res Int. 2021 Mar 19;2021:8883800. doi: 10.1155/2021/8883800. eCollection 2021.
6
MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.MRPL15 是上皮性卵巢癌的一种新型预后生物标志物和治疗靶点。
Cancer Med. 2021 Jun;10(11):3655-3673. doi: 10.1002/cam4.3907. Epub 2021 May 2.
7
Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.通过综合生物信息学分析鉴定 MEG8/miR-378d/SOBP 轴作为一个新的调控网络,并与卵巢癌中的免疫浸润相关。
Cancer Med. 2021 Apr;10(8):2924-2939. doi: 10.1002/cam4.3854. Epub 2021 Mar 19.
8
Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.基于生物信息学分析鉴定与卵巢癌患者发展和预后相关的关键生物标志物。
J Ovarian Res. 2019 Nov 15;12(1):110. doi: 10.1186/s13048-019-0578-1.
9
PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation.PSMD8 可作为卵巢癌 PSMD 家族的潜在生物标志物和治疗靶点:基于生物信息学分析和体外验证。
BMC Cancer. 2023 Jun 22;23(1):573. doi: 10.1186/s12885-023-11017-8.
10
Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.膜联蛋白 A8 可作为卵巢癌潜在的预后生物标志物和治疗靶点:基于膜联蛋白的综合分析。
J Transl Med. 2019 Sep 2;17(1):275. doi: 10.1186/s12967-019-2023-z.

引用本文的文献

1
BOLA family genes are the drivers and potential biomarkers of survival in kidney renal clear cell carcinoma patients.BOLA 家族基因是肾透明细胞癌患者生存的驱动因素和潜在生物标志物。
Saudi Med J. 2024 Nov;45(11):1207-1218. doi: 10.15537/smj.2024.45.11.20240604.
2
Dysregulated inclusion of BOLA3 exon 3 promoted by HNRNPC accelerates the progression of esophageal squamous cell carcinoma.由HNRNPC促进的BOLA3外显子3的异常剪接加速了食管鳞状细胞癌的进展。
Front Med. 2024 Dec;18(6):1035-1053. doi: 10.1007/s11684-024-1068-4. Epub 2024 Oct 26.
3
Integrative analysis of the role of in human pan-cancer.

本文引用的文献

1
Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis.谷氧还蛋白 5 的抑制使顺铂耐药的头颈部癌细胞容易发生铁死亡。
Theranostics. 2020 Jun 19;10(17):7775-7786. doi: 10.7150/thno.46903. eCollection 2020.
2
Targeting nuclear import and export in hematological malignancies.靶向血液系统恶性肿瘤的核输入和输出。
Leukemia. 2020 Nov;34(11):2875-2886. doi: 10.1038/s41375-020-0958-y. Epub 2020 Jul 5.
3
Targeting focal adhesion kinase in cancer cells and the tumor microenvironment.靶向肿瘤细胞和肿瘤微环境中的黏着斑激酶。
对……在人类泛癌中的作用的综合分析 (原文“of”后面缺少具体内容)
Front Genet. 2023 Feb 27;14:1077126. doi: 10.3389/fgene.2023.1077126. eCollection 2023.
4
Prognostic Values of BolA Family Member Expression in Hepatocellular Carcinoma.BolA 家族成员表达在肝细胞癌中的预后价值。
Biomed Res Int. 2022 Aug 16;2022:8360481. doi: 10.1155/2022/8360481. eCollection 2022.
Exp Mol Med. 2020 Jun;52(6):877-886. doi: 10.1038/s12276-020-0447-4. Epub 2020 Jun 9.
4
Chemoresistant ovarian cancer enhances its migration abilities by increasing store-operated Ca entry-mediated turnover of focal adhesions.耐药性卵巢癌通过增加钙库操纵型 Ca2+内流介导的黏着斑周转来增强其迁移能力。
J Biomed Sci. 2020 Feb 21;27(1):36. doi: 10.1186/s12929-020-00630-5.
5
Factors associated with surgical morbidity of primary debulking in epithelial ovarian cancer.上皮性卵巢癌初次肿瘤细胞减灭术手术并发症的相关因素。
Obstet Gynecol Sci. 2020 Jan;63(1):64-71. doi: 10.5468/ogs.2020.63.1.64. Epub 2019 Dec 31.
6
Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium-Chrysin Polyurea Dendrimer Nanoformulation.硒-白杨素聚脲树状大分子纳米制剂通过靶向谷胱甘肽和胱硫醚 β-合酶治疗卵巢癌。
Nutrients. 2019 Oct 19;11(10):2523. doi: 10.3390/nu11102523.
7
Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer.术中胶囊破裂、术后化疗与 I 期上皮性卵巢癌患者的生存
Obstet Gynecol. 2019 Nov;134(5):1017-1026. doi: 10.1097/AOG.0000000000003507.
8
BolA family member 2 enhances cell proliferation and predicts a poor prognosis in hepatocellular carcinoma with tumor hemorrhage.BolA家族成员2促进细胞增殖并预示伴有肿瘤出血的肝细胞癌预后不良。
J Cancer. 2019 Jul 10;10(18):4293-4304. doi: 10.7150/jca.31829. eCollection 2019.
9
miR-22 enhances the radiosensitivity of small-cell lung cancer by targeting the WRNIP1.miR-22 通过靶向 WRNIP1 增强小细胞肺癌的放射敏感性。
J Cell Biochem. 2019 Oct;120(10):17650-17661. doi: 10.1002/jcb.29032. Epub 2019 Jun 12.
10
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.